Carregant...
P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy
Current estimates indicate that the hepatitis C (HCV) is the leading cause of mortality around the world, with infection rates steadily increasing in Egypt. The dual therapy for this silent epidemic with pegylated-interferon-α2b/ribavirin has markedly improved the success rates in genotype-4 patient...
Guardat en:
| Publicat a: | Genes Dis |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Chongqing Medical University
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6150111/ https://ncbi.nlm.nih.gov/pubmed/30258864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gendis.2015.02.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|